Combination Beverage Container and Spittoon
A combination beverage container and spittoon includes a bottom portion including outer wall and a first inner wall defining a spittoon space.
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7785635 | Methods of use of probiotic for companion animals According to the present invention there are provided methods of use in companion animals of probiotic bacteria of the genus Lactobacilli. ... | 08/31/2010 |
| 7780992 | Antiviral medicament There is disclosed a prophylactic and therapeutic antiviral composition and in particular compositions which comprise containing vertebrates kidney as a main component. Use of the composition through parenteral administration for the prevention and treatment of vira... | 08/24/2010 |
| 7320788 | Enzyme treatment of foodstuffs for Celiac Sprue Administering an effective dose of glutenase to a Celiac or dermatitis herpetiformis patient reduces levels of toxic gluten oligopeptides, thereby attenuating or eliminating the damaging effects of gluten. ... | 01/22/2008 |
| 7235262 | Use of bioactive fraction from cow urine distillate (‘’) as a bio-enhancer of anti-infective, anti-cancer agents and nutrients The invention relates to a novel pharmaceutical composition comprising an effective amount of bio-active fraction from cow urine distillate as a bioavailability facilitator and pharmaceutically acceptable additives selected from anticancer compounds, antibiotics, dr... | 06/26/2007 |
| 6896907 | Use of bioactive fraction from cow urine distillate (‘go-mutra’) as a bio-enhancer of anti-infective, anti-cancer agents and nutrients The invention relates to a novel pharmaceutical composition comprising an effective amount of bio-active fraction from cow urine distillate as a bioavailability facilitator and pharmaceutically acceptable additives selected from anticancer compounds, antibiotics, dr... | 05/24/2005 |
| 6890564 | Tissue regenerative composition, method of making, and method of use thereof A matrix, including epithelial basement membrane, for inducing repair of mammalian tissue defects and in vitro cell propagation derived from epithelial tissues of a warm-blooded vertebrate. ... | 05/10/2005 |
| 6887495 | Tissue regenerative composition, method of making, and method of use thereof A matrix, including epithelial basement membrane, for inducing repair of mammalian tissue defects and in vitro cell propagation derived from epithelial tissues of a warm-blooded vertebrate. ... | 05/03/2005 |
| 6861074 | Tissue regenerative composition, method of making, and method of use thereof A matrix, including epithelial basement membrane, for inducing repair of mammalian tissue defects and in vitro cell propagation derived from epithelial tissues of a warm-blooded vertebrate. ... | 03/01/2005 |
| 6849273 | Tissue regenerative composition, method of making, and method of use thereof A matrix, including epithelial basement membrane, for inducing repair of mammalian tissue defects and in vitro cell propagation derived from epithelial tissues of a warm-blooded vertebrate. ... | 02/01/2005 |
| 6783776 | Tissue regenerative composition, method of making, and method of use thereof A matrix, including epithelial basement membrane, for inducing repair of mammalian tissue defects and in vitro cell propagation derived from epithelial tissues of a warm-blooded vertebrate. ... | 08/31/2004 |
| 6649160 | Sertoli cells as transplantation facilitator for cell transplantation A method of producing a sustained localized immunosuppressive effect in localized tissues is achieved by transplanting Sertoli cells proximate to the tissue.... | 11/18/2003 |
| 6579538 | Tissue regenerative compositions for cardiac applications, method of making, and method of use thereof A matrix, including epithelial basement membrane, for inducing repair of mammalian tissue defects and in vitro cell propagation derived from epithelial tissues of a warm-blooded vertebrate.... | 06/17/2003 |
| 6485723 | Enhanced submucosal tissue graft constructs An improved tissue graft construct comprising submucosa of a warm-blooded vertebrate and a preselected group of eukaryotic cells are described. The improved tissue graft constructs can be used in accordance with the present invention to enhance the repair... | 11/26/2002 |
| 6410059 | Pharmaceutical composition containing cow urine distillate and an antibiotic A pharmaceutical composition comprising an antibiotic and cow urine distillate in an amount effective to enhance antimicrobial effect of the antibiotic is disclosed. The antibiotic can be an antifungal agent. The antibiotic can be a quinolone or a fluoroq... | 06/25/2002 |
| 6054142 | Biocompatible devices with foam scaffolds A biocompatible cell device having an internal foam scaffold to provide a growth surface for encapsulated cells which produce a biologically active molecule.... | 04/25/2000 |
| 5928670 | Method of inhibiting aldose reductase in vivo with intrinsic inhibitors of aldose reductase An intrinsic aldose reductase inhibitor is isolated and purified from mammalian cells, such as rat or human kidney cells. The intrinsic aldose reductase inhibitor may be incorporated into pharmaceutical compositions for the treatment of certain conditions... | 07/27/1999 |
| 5824493 | Diagnostic test for interstitial cystitis A method of diagnosing interstitial cystitits in an individual and a kit for the method, comprising the steps of: obtaining primary cultures of urothelial cells; selecting urothelial cells of basal type and producing secondary cultures; measuring in secon... | 10/20/1998 |
| 5738878 | Process for making intrinsic inhibitors of aldose reductase An intrinsic aldose reductase inhibitor is isolated and purified from mammalian cells, such as rat or human kidney cells. The intrinsic aldose reductase inhibitor may be incorporated into pharmaceutical compositions for the treatment of certain conditions... | 04/14/1998 |
| 5702700 | Sertoli cells as neurorecovery inducing cells for Parkinson's disease A method of generating in situ trophic factor production by transplanting Sertoli cells into the central nervous system of a mammal, the cells creating trophic factors in situ.... | 12/30/1997 |
| 5700783 | Method of treating urinary incontinence A method for treating urinary incontinence consisting of injecting human fibrin glue at or near the bladder neck until the urethral outflow resistance is restored. Human fibrin glue is the reaction product of human fibrinogen and thrombin in the presence ... | 12/23/1997 |
| 5695785 | Kidney extract for treatment of systematic lupus erythematosus The invention is directed to a method of treating systematic lupus erythematosus (SLE) in animals, including humans, by the oral administration of kidney extracts to decrease anti-DNA antibody production. The method of the invention includes both prophyla... | 12/09/1997 |
| 5618917 | Methods and compositions for detecting and treating kidney diseases associated with adhesion of crystals to kidney cells An autocrine crystal adhesion inhibitor called CAI is an anionic, sialic acid-containing glycoprotein secreted by kidney epithelial cells that blocks adhesion of calcium oxalate monohydrate (COM) crystals to the cell surfaces. Persons may be classified ac... | 04/08/1997 |
| 5560936 | Intrinsic inhibitors of aldose reductase An intrinsic aldose reductase inhibitor is isolated and purified from mammalian cells, such as rat or human kidney cells. The intrinsic aldose reductase inhibitor may be incorporated into pharmaceutical compositions for the treatment of certain conditions... | 10/01/1996 |
| 5560935 | Physiologically active substances extracted from activated tissues The present invention provides a physiologically active substance which inhibits plasma kallikrein production, improves peripheral blood flow, and exhibits analgesic, antiinflammatory and antiallergic action. The physiologically active substance of the pr... | 10/01/1996 |
| 5554389 | Urinary bladder submucosa derived tissue graft A tissue graft composition comprising bladder submucosal tissue delaminated from abluminal muscle layers and at least the luminal portion of the tunica mucosa of a segment of vertebrate urinary bladder is described. The graft composition can be implanted ... | 09/10/1996 |
| 5510263 | Growth of pancreatic islet-like cell clusters A method for growing endocrine precursor cells in vitro, such as pancreatic islet precursors, by culturing such cells in the presence or absence of cell matrix proteins capable of promoting hemidesmosome formation, such as those produced by the rat bladde... | 04/23/1996 |
| 5476922 | Methods and compositions for the preparation and use of autocrine growth factors Autocrine growth factors and isoforms of those factors have been identified, isolated, purified and manipulated. Nucleic acid segments coding for the factors, and antibodies directed to the factors are also aspects of the present invention. The effect of ... | 12/19/1995 |
| 5324822 | Method of isolating a CA 195-like immunoreactive antigen from human amniotic fluid A method of isolation of a material with similar immunological properties to CA-195 from human amniotic fluid has been disclosed. This material can be substituted for CA-195 in many processes, for example in the preparation of analytical control materials... | 06/28/1994 |
| 5268175 | Cosmetic and/or pharmaceutical compositions and methods for their use Topical cosmetic and pharmaceutical compositions are provided for the external protection of human or animal tissues from contact with heavy metals, and the composition includes a metal sequestering component capable of binding metal ions and a physiologi... | 12/07/1993 |
| 5198216 | Performance enhancing compositions of matter, and methods of preparing and utilizing same A composition for enhancing the performance of animals, such as horses or dogs, is composed of adrenal and pituitary raw tissue concentrates, vitamin C, bioflavonoid complex, pantothenic acid, methionine, choline, vitamin B1, vitamin B2, vitamin B6, niaci... | 03/30/1993 |
| 5057324 | Kallikrein inhibitor substance, a process for preparation and pharmaceutical compositions thereof A physiologically active substance is extracted from infected tissues inoculated with a poxvirus. The novel substance of the present invention has inhibitory action against the formation of kallikrein, thus is useful as drugs such as antiinflammatory, ana... | 10/15/1991 |
| 4985542 | Kit for the determination and diagnosis of non-goodpasture glomerulonephritis Purified glomerular proteoglycans are used as a basis for a diagnostic test for glomerulonephritis in humans involving an immunological reaction between the purified proteoglycans and patient area. A new method for purification of glomeruli proteoglycan a... | 01/15/1991 |
| 4985254 | Method of treating ischemic diseases The present invention relates to physiologically active substances extracted from infected tissues inoculated with a poxvirus. The substances of the present invention have excellent actions to improve blood flow and recover functions of diseased tissues, ... | 01/15/1991 |
| 4963358 | Agent for inhibiting proliferation of human malignant tumor cells An agent for inhibiting proliferation of human malignant tumor cells is obtained by culturing the human malignant tumor cells in a medium and removing the malignant tumor cells from the cultured medium.... | 10/16/1990 |
| 4908206 | Extracts of embryonic organs, process for their preparation and pharmaceutical preparation containing them From organs of embryonic mammalia a new extract of active ingredients is recovered which extract can be used for controlling a reduced blood flow through periperhic organs and through the brain and which extract can be also used for controlling acne vulga... | 03/13/1990 |
| 4749522 | Supercritical fluid extraction of animal derived materials Supercritical fluids (SCF) are found to be useful in extracting desired materials from animal tissues, cells, and organs. By varying the choice of SCF, experimental conditions, and animal source material, one may obtain lipids, proteins, nucleotides, sacc... | 06/07/1988 |
| 4507229 | Tissue protein PP4, a process for isolating it and its use The protein PP4 which has (a) an electrophoretic mobility in the range between that of 댑 and 댒 globulins; (b) an isoelectric point of 4.85b1;0.15; (c) a sedimentation coefficient s20,w0 of 3.3... | 03/26/1985 |
| 4382887 | Novel glycopeptide and methods of isolating and using the same A novel glycopeptide is disclosed, which consists of a sugar moiety having a structural formula ##STR1## and a peptide moiety linking to the sugar moiety through N-glycoside bond. The glycopeptide is isolated from organs of normal animals, especially... | 05/10/1983 |
| 4206201 | Method for preparing a compound called ARL per se and its use as medicinal Compound (hereinafter identified as ARL) useful as a vasodilator and antihypertensive agent. The compound is obtainable using rabbit kidney medulla by first incubating same, second, operating on the incubated material and then purifying the operated upon ... | 06/03/1980 |
| 4083961 | Plasminogen activator pharmaceutical compositions The present invention relates to a pharmaceutical composition comprising a plasminogen activator and a polysaccharide sulphate. The invention also covers a process for preparing the pharmaceutical composition and a process for preparing the plasminogen ac... | 04/11/1978 |